1Driscoll DA, Gross S. Prenatal screening for aneuploidy [ J ]. N Engl J Med ,2009,360:2556-2562.
2Reddy UM. The evolving prenatal screening scene [J]. OBGYN, 2007,110:2-4.
3Malone F, Canick JA, Ball RH,et al. First-trimester or second-trimester screening,or both, for Down's syndrome, first- and second-trimester evaluation of risk (FASTER) research consortium [J]. N Engl J Med,2005,353 : 2001-2011.
4ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, screening for fetal chromosomal abnormalities[J]. OBGYN ,2007,109 : 217-225.
5Kazerouni NN, Currier B, Maim L, et al. Triple-marker prenatal screening program for chromosomal defects[J]. Obstet Gynecol, 2009,114 : 50-58.
6Jaques AM,Collins VR, Muggli EE,et al. Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome [ J ]. Prenat Diagn,2010,30 : 522-530.
7Simpson JL. Choosing the best prenatal screening protocol[ J ]. N Engl J Med,2005,353: 2068-2070.
8Xie ZW, Lu S, Li H. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population[J]. Prenat Diagn ,2010,30 : 74-76.
9Pekarek DM, Chapman VR, Neely CL, et al. Medication effects on midtrimester maternal serum screening[ J ]. Am J Obstet Gynecol,2009,201:622, e1-5.
10Bornstein E, Lenchner E, Donnenfeld A, et al. Comparison of modes of ascertainment for mosaic vs complete trisomy 21 [ J ]. Am J Obstet Gynecol,2009 ,200 :440. e1-5.
